Guidance recommendation and clinical practice issues in neurocognitive assessment tools for schizophrenia
10.3760/cma.j.cn113661-20240713-00235
- VernacularTitle:精神分裂症神经认知评估工具的指引推荐及临床实践应用问题分析
- Author:
Dengtang LIU
1
;
Zheng LU
;
Xin YU
;
Hong DENG
;
Chuan SHI
;
Sha LIU
;
Zhening LIU
;
Tianhong ZHANG
;
Xiaobai LI
;
Chengcheng PU
Author Information
1. 上海交通大学医学院附属精神卫生中心，上海200030
- Publication Type:Journal Article
- Keywords:
Schizophrenia;
Neurocognition;
Assessment tools;
Guideline interpretation
- From:
Chinese Journal of Psychiatry
2024;57(12):789-795
- CountryChina
- Language:Chinese
-
Abstract:
Although cognitive impairment is considered a core symptom of schizophrenia and significantly impacts functional outcomes, it is often overlooked in clinical practice. The European Psychiatric Association released “Guideline on Assessment of Cognitive Impairment in Schizophrenia” in 2022, providing recommendations for research and clinical practice. This paper interprets the neurocognitive aspects of schizophrenia covered in the guidelines, introduces neurocognitive assessment tools used in China and their application settings, examines the relationship between subjective and objective assessments of cognitive impairment, and briefly discusses the connections between neurocognition and positive and negative symptoms. The paper also considers the future development of neurocognitive assessment tools in China.
